Awarded Silver for Startup of the Year and Best CTOK2 Cyber Security, provider of the next generation in application workload protection, today announced that it has won three Globee® Awards in the 2021 Cyber Security Global Excellence Awards.
In addition to winning Gold for Zero Day Exploits, K2 won Silver for Startup of the Year and Silver for Best CTO.
K2 was named a winner in every category for which the company was nominated.
Now in their 17th year, the Cyber Security Global Excellence Awards recognize the cyber security and information technology providers whose ground-breaking products and services help raise the bar in all areas of security.“We are thrilled that our pioneering work in detecting and preventing zero day exploits has been recognized by such a longstanding awards program,” said Pravin Madhani, Co-Founder and CEO, K2 Cyber Security.
“With the move to the cloud, applications offer a broader attack surface for cyber criminals.
Zero day exploits, based on new vulnerabilities, are expected to double in the next year, yet nearly 70% of zero day attacks go undetected.K2’s Security Platform offers a revolutionary approach to the detection of zero day as well as known vulnerabilities.
The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research.
The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market.
A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality.
Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities.
Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.
A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years.
Vitamin K2 Market OverviewThe global vitamin K2 market is estimated to touch a size of USD 228.27 million by 2023.
Vitamin K2 is highly essential in human diets owing to its ability to supply sufficient amounts of calcium to the body.
Osteocalcin activated by vitamin K2 ensures the absorption of calcium into the bone matrix and preventing its accumulation in the arteries.Increasing rate of vitamin deficiency disorders has created the need for nutraceuticals or supplements inclusive of vitamin K2.
High incidence of osteoporosis which prevents formation of new tissues can be treated with regular supply of vitamins.Get Free Sample at https://www.marketresearchfuture.com/sample_request/7495Vitamin K2 Market Competitive Analysis:Major players in the vitamin K2 market include,Danisco A/SKyowa Hakko Bio Co. Ltd.DSMGnosis SpAFrutaromKappa BioscienceSeebio BiotechNattoPharmaViridis BioPharmaGeneferm Biotechnology Co. Ltd.Collaborations, investments in R, and expansions are strategies incorporated by these players to increase their profit margins.
The intake of these pills can reduce hardening in the arteries and reduce the probability of cardiovascular diseases.Vitamin K2 Market Segmentation Analysis:The global vitamin K2 market is segmented by Product Type, Source, Form, and Application.By product type, MK-7 accounted for 71.61% market share in 2017, followed by MK-4 (21.87%) and others (6.52%).
On the other hand, the synthetic segment is projected to reach USD 82.54 million by 2023, growing at 31.73% CAGR over the assessment period.By form, powder held 52.75% share in 2017, followed by oil (36.96%) and others (10.29%).
The global “Vitamin K2 Market” research report addresses the need for an industry- and economy-wide database beneficial for the business management that could potentially offer development and profitability in the market.
It also draws focus on technologies, volume, materials & markets, and in-depth market analysis of the Vitamin K2 sector.
The study has a section dedicated to profiling the dominant companies in the market while providing their market shares.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/112The Vitamin K2 market intelligence study includes a separate section dedicated to crucial parameters like the pricing structure of vital feedstock and value chain analysis, along with the study of major suppliers of the raw materials.
It also offers other pivotal information about the Vitamin K2 market as part of a wide-ranging analysis of the supply chain, along with other aspects like prominent distributors and the consumer base.In market segmentation by manufacturers, the report covers the following companies- Kappa Bioscience, NattoPharma, Gnosis, DSM, Viridis BioPharma, Frutarom, DuPont Nutrition & Health, GeneFerm Biotechnology, Shanghai Reson Biotech, Guangdong Goodscend, Seebio Biotech, Kyowa HakkoFurthermore, the research report projects the changes in the supply-demand dynamics, market value, market competition, leading market players, and market estimations from 2019 to 2022.
Click here to know more @ https://www.reportsanddata.com/discount-enquiry-form/112Scope of the Research:The report offers an in-depth assessment of the competitive scenario, taking into consideration the market shares held by leading companies.
It also discusses the supply-demand dynamics and key participants with vital business intelligence and helps them with a research-backed forecast for the global Vitamin K2 market.The evaluation includes the forecast, a summary of the competitive landscape, the market shares of competitors, as well as the market trends, demands, opportunities and challenges existing in the sector, and elaborate product analysis.
Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), Source (Natural, Synthetic), Form (Oil, Powder, Others), Application (Nutraceutical & Food, Pharmaceutical) and Region - Forecast till 2027Overview:Vitamin K2, or menaquinones, is a group of compounds that is known for their ability to check cardiovascular diseases and bone diseases.
The vitamin assists in the absorption of calcium by the bone matrix and arrests its deposition in the arteries.
The global vitamin K2 market is all set to score a valuation of USD 228.27 million by 2023.
This segmentation provides a better insight regarding factors that can trigger change in the market of the coming years.Based on the product type, the global vitamin K2 market can be segmented into MK-4, MK-7, and others.
The MK-4 segment can surpass USD 48.93 million with a 30.63% CAGR during the forecast period.Based on the source, the vitamin K2 market can be segmented into natural and synthetic.
On the other hand, the synthetic segment can cross the estimated valuation of USD 82.54 million by 2023 by taking a speed of around 31.73% CAGR over the review period.Based on the form, the vitamin K2 market can be segmented into oil and powder.
Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), Source (Natural, Synthetic), Form (Oil, Powder, Others), Application (Nutraceutical & Food, Pharmaceutical) and Region - Forecast till 2027Overview:Vitamin K2, or menaquinones, is a group of compounds that is known for their ability to check cardiovascular diseases and bone diseases.
The vitamin assists in the absorption of calcium by the bone matrix and arrests its deposition in the arteries.
The global vitamin K2 market is all set to score a valuation of USD 228.27 million by 2023.
This segmentation provides a better insight regarding factors that can trigger change in the market of the coming years.Based on the product type, the global vitamin K2 market can be segmented into MK-4, MK-7, and others.
The MK-4 segment can surpass USD 48.93 million with a 30.63% CAGR during the forecast period.Based on the source, the vitamin K2 market can be segmented into natural and synthetic.
On the other hand, the synthetic segment can cross the estimated valuation of USD 82.54 million by 2023 by taking a speed of around 31.73% CAGR over the review period.Based on the form, the vitamin K2 market can be segmented into oil and powder.
Awarded Silver for Startup of the Year and Best CTOK2 Cyber Security, provider of the next generation in application workload protection, today announced that it has won three Globee® Awards in the 2021 Cyber Security Global Excellence Awards.
In addition to winning Gold for Zero Day Exploits, K2 won Silver for Startup of the Year and Silver for Best CTO.
K2 was named a winner in every category for which the company was nominated.
Now in their 17th year, the Cyber Security Global Excellence Awards recognize the cyber security and information technology providers whose ground-breaking products and services help raise the bar in all areas of security.“We are thrilled that our pioneering work in detecting and preventing zero day exploits has been recognized by such a longstanding awards program,” said Pravin Madhani, Co-Founder and CEO, K2 Cyber Security.
“With the move to the cloud, applications offer a broader attack surface for cyber criminals.
Zero day exploits, based on new vulnerabilities, are expected to double in the next year, yet nearly 70% of zero day attacks go undetected.K2’s Security Platform offers a revolutionary approach to the detection of zero day as well as known vulnerabilities.
Vitamin K2 Market OverviewThe global vitamin K2 market is estimated to touch a size of USD 228.27 million by 2023.
Vitamin K2 is highly essential in human diets owing to its ability to supply sufficient amounts of calcium to the body.
Osteocalcin activated by vitamin K2 ensures the absorption of calcium into the bone matrix and preventing its accumulation in the arteries.Increasing rate of vitamin deficiency disorders has created the need for nutraceuticals or supplements inclusive of vitamin K2.
High incidence of osteoporosis which prevents formation of new tissues can be treated with regular supply of vitamins.Get Free Sample at https://www.marketresearchfuture.com/sample_request/7495Vitamin K2 Market Competitive Analysis:Major players in the vitamin K2 market include,Danisco A/SKyowa Hakko Bio Co. Ltd.DSMGnosis SpAFrutaromKappa BioscienceSeebio BiotechNattoPharmaViridis BioPharmaGeneferm Biotechnology Co. Ltd.Collaborations, investments in R, and expansions are strategies incorporated by these players to increase their profit margins.
The intake of these pills can reduce hardening in the arteries and reduce the probability of cardiovascular diseases.Vitamin K2 Market Segmentation Analysis:The global vitamin K2 market is segmented by Product Type, Source, Form, and Application.By product type, MK-7 accounted for 71.61% market share in 2017, followed by MK-4 (21.87%) and others (6.52%).
On the other hand, the synthetic segment is projected to reach USD 82.54 million by 2023, growing at 31.73% CAGR over the assessment period.By form, powder held 52.75% share in 2017, followed by oil (36.96%) and others (10.29%).
Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), Source (Natural, Synthetic), Form (Oil, Powder, Others), Application (Nutraceutical & Food, Pharmaceutical) and Region - Forecast till 2027Overview:Vitamin K2, or menaquinones, is a group of compounds that is known for their ability to check cardiovascular diseases and bone diseases.
The vitamin assists in the absorption of calcium by the bone matrix and arrests its deposition in the arteries.
The global vitamin K2 market is all set to score a valuation of USD 228.27 million by 2023.
This segmentation provides a better insight regarding factors that can trigger change in the market of the coming years.Based on the product type, the global vitamin K2 market can be segmented into MK-4, MK-7, and others.
The MK-4 segment can surpass USD 48.93 million with a 30.63% CAGR during the forecast period.Based on the source, the vitamin K2 market can be segmented into natural and synthetic.
On the other hand, the synthetic segment can cross the estimated valuation of USD 82.54 million by 2023 by taking a speed of around 31.73% CAGR over the review period.Based on the form, the vitamin K2 market can be segmented into oil and powder.
The global Vitamin K2 market size is expected to reach USD 290.3 million by 2026 according to a new study by Polaris Market Research.
The alarming cases of vitamin deficiency in humans are anticipated to be a primary trigger for demand in the global market.
A study conducted by the Food & Agriculture Organization of United Nations (FAO) in the year 2018 revealed that vitamin K deficiency bleeding (VKDB) in infants has emerged to be a major concern for infant mortality.
Production method of the ingredient is a crucial concern particularly in the pharmaceutical industry, as manufacturers have to keenly assess the drug testing criteria put forth by governing authorities.
Powders and oils are the primary forms through which vitamin K2 would be integrated in foods.
A drastic increase in the consumption of functional foods by the citizens of Australia, China, and India are likely to speed up the demand of vitamin K2 in Asia Pacific over the next five years.
The global “Vitamin K2 Market” research report addresses the need for an industry- and economy-wide database beneficial for the business management that could potentially offer development and profitability in the market.
It also draws focus on technologies, volume, materials & markets, and in-depth market analysis of the Vitamin K2 sector.
The study has a section dedicated to profiling the dominant companies in the market while providing their market shares.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/112The Vitamin K2 market intelligence study includes a separate section dedicated to crucial parameters like the pricing structure of vital feedstock and value chain analysis, along with the study of major suppliers of the raw materials.
It also offers other pivotal information about the Vitamin K2 market as part of a wide-ranging analysis of the supply chain, along with other aspects like prominent distributors and the consumer base.In market segmentation by manufacturers, the report covers the following companies- Kappa Bioscience, NattoPharma, Gnosis, DSM, Viridis BioPharma, Frutarom, DuPont Nutrition & Health, GeneFerm Biotechnology, Shanghai Reson Biotech, Guangdong Goodscend, Seebio Biotech, Kyowa HakkoFurthermore, the research report projects the changes in the supply-demand dynamics, market value, market competition, leading market players, and market estimations from 2019 to 2022.
Click here to know more @ https://www.reportsanddata.com/discount-enquiry-form/112Scope of the Research:The report offers an in-depth assessment of the competitive scenario, taking into consideration the market shares held by leading companies.
It also discusses the supply-demand dynamics and key participants with vital business intelligence and helps them with a research-backed forecast for the global Vitamin K2 market.The evaluation includes the forecast, a summary of the competitive landscape, the market shares of competitors, as well as the market trends, demands, opportunities and challenges existing in the sector, and elaborate product analysis.
Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), Source (Natural, Synthetic), Form (Oil, Powder, Others), Application (Nutraceutical & Food, Pharmaceutical) and Region - Forecast till 2027Overview:Vitamin K2, or menaquinones, is a group of compounds that is known for their ability to check cardiovascular diseases and bone diseases.
The vitamin assists in the absorption of calcium by the bone matrix and arrests its deposition in the arteries.
The global vitamin K2 market is all set to score a valuation of USD 228.27 million by 2023.
This segmentation provides a better insight regarding factors that can trigger change in the market of the coming years.Based on the product type, the global vitamin K2 market can be segmented into MK-4, MK-7, and others.
The MK-4 segment can surpass USD 48.93 million with a 30.63% CAGR during the forecast period.Based on the source, the vitamin K2 market can be segmented into natural and synthetic.
On the other hand, the synthetic segment can cross the estimated valuation of USD 82.54 million by 2023 by taking a speed of around 31.73% CAGR over the review period.Based on the form, the vitamin K2 market can be segmented into oil and powder.